Who We Are
ImmunoGen is a clinical-stage biotechnology company that develops targeted anticancer therapeutics with its proprietary antibody-drug conjugate (ADC) technology. The Company's lead product candidate, mirvetuximab soravtansine, is a potential treatment for folate receptor α-positive ovarian cancers and other solid tumors. Leading healthcare companies have licensed rights to use ImmunoGen's technology to develop novel anticancer therapies, and Roche's marketed product, Kadcyla, utilizes ImmunoGen's ADC technology. More information about the Company can be found at www.immunogen.com.
The Opportunity
ImmunoGen, Inc. is in search of a highly motivated individual to join the Antibody Engineering group. He/she will contribute to the Discovery projects portfolio by supporting the efforts to humanize and optimize lead antibody candidates while helping to drive the new technology platform. This RA I/II will be primarily responsible for performing gene design, cloning, and expression in both mammalian and prokaryotic cells. Other activities will include antibody/protein biochemical characterization and binding analysis using ELISA and Biacore/Octet.
Who You Are
The qualified candidate will possess a BS in biology or related discipline and have 1- 3 years of extensive hands on laboratory experience with:
- Standard molecular biology techniques
- Mammalian tissue culture
- A familiarity with DNA/protein sequence analysis and editing software
- Experience with ELISA, Biacore/Octet
- High throughput antibody screening techniques
- The ideal candidate should also have strong organizational skills and demonstrated ability to handle multiple tasks and work in a team environment.
ImmunoGen, Inc. is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status.
ImmunoGen, Inc. does not accept non-solicited resumes or candidate submittals from search/recruiting agencies not already on ImmunoGen, Inc.’s approved agency list. Unsolicited resumes or candidate information submitted to ImmunoGen, Inc. by search/recruiting agencies not already on ImmunoGen, Inc. approved agency list shall become the property of ImmunoGen, Inc. and if the candidate is subsequently hired by ImmunoGen, Inc., ImmunoGen, Inc. shall not owe any fee to the submitting agency.